Ascendian Healthcare Consulting Service Line

A study by Cutting Edge Information found that pharmaceutical companies measure cost per patient per month to allow trials of different sizes and durations to be compared easily. This measurement also helps to illustrate the high costs associated with delays.


The U.S. Senate passed legislation Sept. 26 to reauthorize, extend and improve operations of the Federal Helium Reserve in Texas, which will guarantee a stable supply of the gas used for cooling magnetic resonance imaging (MRI) systems.

 


IMRIS Inc. and Varian Medical Systems announced that data presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting demonstrates the potential to direct state-of-the-art radiation treatments using diagnostic-quality magnetic resonance (MR)  images at each treatment session.



The highest levels of radiation dose in medical imaging are reported in nuclear medicine and pressure is growing for lower dose.



A large number of emergency room visits are for chest pain evaluation, and many hospitals are adopting CT angiography as a primary test to quickly rule-out coronary disease.


This year the program has set a goal for 100,000 women to make the promise and pass it on to all of the women in their lives. Help reach the goal of 100,000 promises. Make the promise. Then pass it on.

There are numerous ways you can support the American Cancer Society’s mission to help people stay well, get well, find cures and fight back against cancer. Learn more today.

When leaders at Methodist Le Bonheur Healthcare (MLH), a not-for-profit health system based in Memphis, Tenn., saw the opportunity to standardize their suite of diagnostic imaging solutions, they capitalized on it. The seven-hospital system will deploy McKesson’s portfolio of enterprise medical imaging products across its various facilities to help improve physician collaboration, streamline data management and simplify its imaging archive process with a single point of access.

 
 

Early-stage breast cancer patients who receive external beam therapy (XRT) are not at higher risk for serious long-term side effects in the chest area, including increase in deaths from cardiac disease and secondary malignancies, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting.


Subscribe Now